BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1679715)

  • 1. Interleukin 4 receptor targeted cytotoxicity: genetic construction and in vivo immunosuppressive activity of a diphtheria toxin-related murine interleukin 4 fusion protein.
    Lakkis F; Steele A; Pacheco-Silva A; Rubin-Kelley V; Strom TB; Murphy JR
    Eur J Immunol; 1991 Sep; 21(9):2253-8. PubMed ID: 1679715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 7 (IL-7) receptor-specific cell killing by DAB389 IL-7: a novel agent for the elimination of IL-7 receptor positive cells.
    Sweeney EB; Foss FM; Murphy JR; vanderSpek JC
    Bioconjug Chem; 1998; 9(2):201-7. PubMed ID: 9548535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP.
    vanderSpek JC; Sutherland JA; Zeng H; Battey JF; Jensen RT; Murphy JR
    Cancer Res; 1997 Jan; 57(2):290-4. PubMed ID: 9000570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phe496 and Leu497 are essential for receptor binding and cytotoxic action of the murine interleukin-4 receptor targeted fusion toxin DAB389-mIL-4.
    Lakkis F; Landgraf B; Wen Z; Strom TB; Murphy JR
    Protein Eng; 1992 Apr; 5(3):241-8. PubMed ID: 1409544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia.
    Kiyokawa T; Shirono K; Hattori T; Nishimura H; Yamaguchi K; Nichols JC; Strom TB; Murphy JR; Takatsuki K
    Cancer Res; 1989 Jul; 49(14):4042-6. PubMed ID: 2786749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response.
    Volk HD; Müller S; Yarkoni S; Diamantstein T; Lorberboum-Galski H
    J Immunol; 1994 Sep; 153(6):2497-505. PubMed ID: 8077661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells.
    Waters CA; Schimke PA; Snider CE; Itoh K; Smith KA; Nichols JC; Strom TB; Murphy JR
    Eur J Immunol; 1990 Apr; 20(4):785-91. PubMed ID: 2140788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones.
    Bastos MG; Pankewycz O; Rubin-Kelley VE; Murphy JR; Strom TB
    J Immunol; 1990 Dec; 145(11):3535-9. PubMed ID: 2147194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and receptor specific toxicity of two diphtheria toxin-related interleukin-3 fusion proteins DAB389-mIL-3 and DAB389-(Gly4Ser)2-mIL-3.
    Liger D; vanderSpek JC; Gaillard C; Cansier C; Murphy JR; Leboulch P; Gillet D
    FEBS Lett; 1997 Apr; 406(1-2):157-61. PubMed ID: 9109408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and expression of the fusion protein DT389-hIL-13 and its cytotoxicity to glioma cell lines].
    Tuo HZ; Wang JW; Wang DX; Li JM; Ouyang J; Hong T
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1024-8. PubMed ID: 15312540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins.
    Murphy JR; Bishai W; Williams D; Bacha P; Borowski M; Parker K; Boyd J; Waters C; Strom TB
    Biochem Soc Symp; 1987; 53():9-23. PubMed ID: 2847744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin.
    Puri RK; Ogata M; Leland P; Feldman GM; FitzGerald D; Pastan I
    Cancer Res; 1991 Jun; 51(11):3011-7. PubMed ID: 2032239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein.
    Chadwick DE; Jean LF; Jamal N; Messner HA; Murphy JR; Minden MD
    Br J Haematol; 1993 Sep; 85(1):25-36. PubMed ID: 8251407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein.
    Bacha P; Williams DP; Waters C; Williams JM; Murphy JR; Strom TB
    J Exp Med; 1988 Feb; 167(2):612-22. PubMed ID: 3126255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.
    Pacheco-Silva A; Bastos MG; Muggia RA; Pankewycz O; Nichols J; Murphy JR; Strom TB; Rubin-Kelley VE
    Eur J Immunol; 1992 Mar; 22(3):697-702. PubMed ID: 1547815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic construction and characterization of the diphtheria toxin-related interleukin 15 fusion protein DAB389 sIL-15.
    vanderSpek JC; Sutherland J; Sampson E; Murphy JR
    Protein Eng; 1995 Dec; 8(12):1317-21. PubMed ID: 8869645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure/function analysis of the transmembrane domain of DAB389-interleukin-2, an interleukin-2 receptor-targeted fusion toxin. The amphipathic helical region of the transmembrane domain is essential for the efficient delivery of the catalytic domain to the cytosol of target cells.
    vanderSpek JC; Mindell JA; Finkelstein A; Murphy JR
    J Biol Chem; 1993 Jun; 268(16):12077-82. PubMed ID: 8505330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphtheria toxin receptor-binding domain substitution with interleukin 6: genetic construction and interleukin 6 receptor-specific action of a diphtheria toxin-related interleukin 6 fusion protein.
    Jean LF; Murphy JR
    Protein Eng; 1991 Dec; 4(8):989-94. PubMed ID: 1817263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphtheria toxin fused to variant interleukin-3 provides enhanced binding to the interleukin-3 receptor and more potent leukemia cell cytotoxicity.
    Liu TF; Urieto JO; Moore JE; Miller MS; Lowe AC; Thorburn A; Frankel AE
    Exp Hematol; 2004 Mar; 32(3):277-81. PubMed ID: 15003313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction and prokaryotic expression of a recombinant immunotoxin fused with mouse interleukin 18 and truncated Pseudomonas exotoxin].
    Li H; Li MY; Jiang ZH; Lü ML; Zhang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):753-6. PubMed ID: 15573745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.